GLN-EZETIMIBE
Identification of Gln-Ezetimibe
| No description |
Google image searchProduct monograph
Active ingredient
ezetimibe, 10 MG
DIN: 02460750
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: GLENMARK PHARMACEUTICALS CANADA INC.
Date: 17-JUN-2024
ATC:
- C10 — LIPID MODIFYING AGENTS (ATC, ATC/DDD, )
- C10A — LIPID MODIFYING AGENTS, PLAIN (ATC, ATC/DDD)
- C10AX — Other lipid modifying agents (ATC, ATC/DDD)
- C10AX09 — EZETIMIBE (ATC/DDD)
Reference brand drug: Ezetrol
Pharmaceutical standard: USP
